E. Dumkow E. Bias Vaishnav Chen

51 SUNDAY SCIENTIFIC SESSIONS Final Program H-228 In-Hospital Mortality from Acute Myocardial Infarction: HIV Sero-Positive vs. Sero-Negative Individuals D. D. Pearce 1 , C. Ani 2 , Y. Espinosa-Silva 3 , R. Clark 3 , K. Fatima 3 , M. Rahman 3 , E. Diebolt 3 , B. Ovbiagele 4 ; 1 Loma Linda Univ., Loma Linda, CA, 2 Charles Drew Univ., Compton, CA, 3 Western Univ. of Hlth. Sci., Coll. of Osteopathic Med. of the Pacific, Pomona, CA, 4 Univ. of California, San Diego, San Diego, CA. H-229 Early Onset and Late Diagnosis of CAD in HIV+ Persons C. Kaiser 1 , T. Chin 1 , S. Napravnik 2 , L. Yang 1 , M. Tipton 2 , J. Eron 2 , C. Hicks 1 ; 1 Duke Univ. Med. Ctr., Durham, NC, 2 UNC, Chapel Hill, NC. H-230 Comparison of Predicted Cardiovascular Disease Risk Be- tween HIV-Infected and Non-Infected Koreans S. Kim, Y. Kim, M. Kim, J. Song, D. Oh, J. Ahn, N. Ku, H. Kim, S. Jeong, S. Han, C. Kim, Y. Song, J. Choi, J. Kim; Yonsei Univ. Coll. of Med., Seoul, Korea, Republic of. H-231 An Observational Study of Bone Status in HIV-Infected Patients

L. Lemeunier

1 , N. Viget 1 , E. Biver 2 , B. Cortet 2 , E. Senneville 1 ; 1 Tourcoing Hosp., Tourcoing, France, 2 CHRU Lille, Lille, France. H-232 Psychiatric Disorders among HIV Patients in Southern Israel: A Comparison between African-Origin and Caucasian Populations I. Dotan, R. Toledano, D. Buskila, F. Schlaeffer, R. Smolyakov, L. Saidel- Odes, V. Novack, A. Borer, K. Riesenberg; Soroka Univ. Med. Ctr. SUMC and Faculty of Hlth. Sci., Ben Gurion Univ. of the Negev, Beer Sheva, Israel. ------------------------------------------------------------------------ 020 K Poster Session Antibiotic Stewardship and Usage Sunday, 11:30 a.m.–1:30 p.m. . . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: K-233 Regional Antibiogram ABG of ESKAPE Pathogens: A New Direction for Resistance Trends in Antimicrobial Stewardship AMS

A. R. Caffrey

1,2 , H. J. Morrill 3 , K. M. Babcock 3 , J. Dworkin 4 , K. L. LaPlante 3,2 ; 1 Univ. of Rhode Island Coll. of Pharmacy, Kingston, RI, 2 Univ. of Rhode Island, Coll. of Pharmacy, Kingston, RI, 3 Providence VA ID Res. Program, Providence, RI, 4 Brown Univ., Providence, RI. K-234 Control of the Prescription of Carbapenems in a French Hos- pital: Impact of the Hospital Antibiotic Management Team C. Couzigou, J. C. Nguyen, B. Vidal, I. Tersen, J. Loriau, M. D. Kitzis; Hosp. Saint-Joseph, Paris, France. K-235 The Role of an Anti-Microbial Stewardship Program ASP in an Adult Renal Department

Y. Cai, ASP Team SGH, M. P. Chlebicki, A. L. Kwa; Singapore Gen. Hosp., Singapore, Singapore.

K-236 Little Steps Towards Infection Control: Where There is a Will, There is a Way- Even in the NDM-1 Era

A. Ghafur, V. P. R. Lakshmi, K. Chandra, S. Bharadwaj, M. Anna; Apollo Hosp., Chennai, India.

K-237 How Carbapenems are Used in French Health-Care Settings in 2011?

R. Gauzit

1 , Y. Pean 2 , S. Alfandari 3 , J. Bru 4 , J. P. Bedos 5 , C. Rabaud 6 , J. Robert 7 , SPILF, ONERBA; 1 Hotel-Dieu, Paris, France, 2 L’IMM, Paris, France, 3 CH, Tourcoing, France, 4 CH, Annecy, France, 5 CH, Versailles, France, 6 CHU, Nancy, France, 7 Faculte PM Curie, Paris, France. K-238 Optimal Antibiotic Treatment in Hospitals- Meta-Analysis and Models

P. Abel Zur Wiesch

1 , R. D. Kouyos 2 , S. Abel 1 , L. Laser 3 , S. Bonhoeffer 3 ; 1 Brigham and Women’s Hosp., Harvard Med. Sch., Boston, MA, 2 Princeton Univ., Princeton, NJ, 3 ETH Zurich, Zurich, Switzerland. K-239 Costs of Outpatient Parenteral Antibiotic Therapy OPAT for the Management of Gram+ Acute Bacterial Skin and Soft Tissue Infections abSSTIs

A. Khachatryan

1 , V. Ektare 1 , M. Xue 1 , M. Dunne 2 , J. Stephens 1 ; 1 Pharmerit Intl., Bethesda, 2 Durata Therapeutics, Morristown, NJ. K-240 Implementation of a Collaborative Antimicrobial Culture Follow-Up Program in the Emergency Department ED

L. E. Dumkow

1 , R. M. Chambers 1 , N. C. MacDonald 1 , J. J. Carreno 1,2 , M. K. Malhotra 1 , S. L. Davis 1,2 ; 1 Henry Ford Hosp., Detroit, MI, 2 Wayne State Univ., Detroit, MI. K-241 Impact of a Pharmacy Driven Intervention to Reduce Time to Initiation of Empiric Antibiotic Therapy in Bacteremic Patients

T. E. Bias

1,2 , W. Vincent 2,1 , N. Trustman 2 , L. Berkowitz 1 , V. Venugopalan 1,2 ; 1 The Brooklyn Hosp. Ctr., Brooklyn, NY, 2 Arnold Marie Schwartz Coll. of Pharmacy and Hlth. Sci. Long Island Univ., Brooklyn, NY. K-242 Early Intervention of PiperacillinTazobactam in the Accident and Emergency Department at Sultan Qaboos University Hospital in Oman: A Boon or an Anathema?

R. Vaishnav

1 , R. S. H. Al-Buridi 2,3 ; 1 Coll. of Med. Hlth. Sci., Sultan Qaboos Univ., Al-Khod, Muscat, Oman, 2 Coll. of Med. Hlth. Sci., Al-Khod, Muscat, Oman, 3 Coll. of Med. Hlth. Sci., Sultan Qaboos Univ., Muscat, Oman. ------------------------------------------------------------------------ 021 K Poster Session Infection Control and the Environment Sunday, 11:30 a.m.–1:30 p.m. . . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: K-243 Will Environmental Disinfection Decrease Healthcare- Associated Infection HAI?: A Systematic Review

H. Chen

1 , C. Yau 1 , A. Wong 1 , P. Ching 2 , W. Seto 2 ; 1 CHP, HKSAR, Hong Kong, 2 WHO Collaborative Ctr., HKSAR, Hong Kong. K-244 What to Breath?: Performance Analysis of Air Samplers in Operating Rooms

L. Ummels